About Us

MedLife is the network of life sciences in the technology region of Aachen. Following the fusion of LifeTecAachen-Jülich e.V. with the Aachen Centre of Competence for Medical Technology (AKM) a powerful branch association was formed that includes more than 80 members.
We offer events and services within the sectors of medical technology, biotechnology, pharmaceuticals and health management. We are the contact for entrepreneurs and scientists, who seek exchange with other protagonists in life sciences as well as proficient consulting and support regarding innovative plans and business ideas.
Our goal is to expand MedLife e.V. to an agile network across locations that cover the entire value chain in life sciences, from ideas up to the market-ready product.
Additionally, the attached GmbH (former akm Innovationsmanagement GmbH) handles the sectors Clustermanagement and Project Management and offers services for companies such as business and innovation consulting.
Learn more about our performance and services of MedLife and become a part of this unique and future-oriented network.

Aachen-based Startup Company closes $ 10 Million Series A Financing

Nov, 2018

The Aachen-based startup Protembis GmbH receives $ 10 Million capital requirements especially with the participation of Seed Fonds III for the region of Aachen and Mönchengladbach GmbH & Co. KG and Abiomed Inc. With this, the company wants to develop its „ProtEmbo“ technology for the minimization of the risk of stroke in the case of heart valve intervention to market maturity. more

Grünenthal selected as one of the best employers in Europe

Aug, 2018

After 2012 and 2013 the pharmaceutical company Grünenthal is again selected as one of the best employers in Europe. Due to its successes in the countries Italy, Portugal and Spain, Grünenthal impressed the jury with its positive business culture. more

AC²-Gründerpreis 2018 for start-up of FH Aachen

Aug, 2018

Peter Linder and Dr. Matthias Großmann of the spin-off innoVitro GmbH won the AC²-Gründerwettbewerb (founders cempetition) with their innovative method of analysis to examine agents on artificially generated myocardial tissue. The method based on the "CellDrum" technology renders animal testing increasingly redundant. more

Opening of the Center for Biohybrid Medical Systems (CBMS)

Jul, 2018

After three years of construction, the Center for Biohybrid Medical Systems (CBMS) invited its friends and partners to a ceremonial symposium. Within the CBMS researchers from different disciplines collaborate to jointly develop biohybrid medical systems. more

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny